Trial Information

The Influence of the Radiotherapy or Stereotactic Radiosurgery on the Cognitive Function of the Patients With the Neurotrax Assessment System and a Cognitive Questionnaire.

The basic cognitive function and QOL of 150 oncologic patients that undergone Radiotherapy
or Radiosurgery treatment to the brain due to primary tumor, metastases or increased risk of
brain metastases, will be assessed at 3 time points: before the treatment, immediately after
the treatment, and on the next follow up visit. The assessment tools that will be used are
Neurotrax standard cognitive computerized tests and 2 short questionnaires.Patients that
will receive a one-day treatment will be tested on 2 time points only- before the treatment
and on FU.The research will reveal the positive and the negative influences of the
Radiotherapy, along with the assessment of norms for the cognitive function and quality of
life of oncologic patients being treated by RT.Eligibility criteria:oncologic patients of
both genders, with primary brain tumors, metastases or with increased risk of brain
metastases, that are referred to conformal/palliative or preventive Radiotherapy treatment
or to Stereotactic Radiosurgery, who are able to follow instructions in Hebrew.The
participants will be 20-80 years old.Main comparisons will be performed between the
cognitive tests results on 3 time points mentioned. The study will continue until the needed
number of participants will be achieved.